{"transactions":[{"id":687004,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2026-08-14T21:11:50.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001836067-26-000010","document":"wk-form4_1786741908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000010/wk-form4_1786741908.xml","form_type":"4"}},{"id":687003,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-14T21:11:50.000Z","date":"2026-08-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":363,"price":46.57,"value":16904.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":13979,"source":{"system":"sec-edgar","filing":"0001836067-26-000010","document":"wk-form4_1786741908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000010/wk-form4_1786741908.xml","form_type":"4"}},{"id":687002,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-08-14T21:11:50.000Z","date":"2026-08-12","kind":"exercise","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 251 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":14342,"source":{"system":"sec-edgar","filing":"0001836067-26-000010","document":"wk-form4_1786741908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000010/wk-form4_1786741908.xml","form_type":"4"}},{"id":700023,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2026-07-31T21:04:03.000Z","date":"2026-07-29","kind":"grant","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 19, 2025, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2025."}],"balance_after":750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001836067-26-000008","document":"wk-form4_1785531841.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000008/wk-form4_1785531841.xml","form_type":"4"}},{"id":879816,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-26T21:17:42.000Z","date":"2026-02-25","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":1250,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001836067-26-000006","document":"wk-form4_1772140659.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000006/wk-form4_1772140659.xml","form_type":"4"}},{"id":879815,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:17:42.000Z","date":"2026-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":675,"price":50.69,"value":34215.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":13341,"source":{"system":"sec-edgar","filing":"0001836067-26-000006","document":"wk-form4_1772140659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000006/wk-form4_1772140659.xml","form_type":"4"}},{"id":879814,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-26T21:17:42.000Z","date":"2026-02-25","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14016,"source":{"system":"sec-edgar","filing":"0001836067-26-000006","document":"wk-form4_1772140659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000006/wk-form4_1772140659.xml","form_type":"4"}},{"id":882149,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T21:51:15.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001836067-26-000004","document":"wk-form4_1772056270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000004/wk-form4_1772056270.xml","form_type":"4"}},{"id":882148,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T21:51:15.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001836067-26-000004","document":"wk-form4_1772056270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000004/wk-form4_1772056270.xml","form_type":"4"}},{"id":882147,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-25T21:51:15.000Z","date":"2026-02-24","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."}],"balance_after":3375,"derivative":{"underlying":"Common Stock","underlying_shares":1125},"source":{"system":"sec-edgar","filing":"0001836067-26-000004","document":"wk-form4_1772056270.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000004/wk-form4_1772056270.xml","form_type":"4"}},{"id":882146,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:51:15.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":12766,"source":{"system":"sec-edgar","filing":"0001836067-26-000004","document":"wk-form4_1772056270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000004/wk-form4_1772056270.xml","form_type":"4"}},{"id":882145,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:51:15.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13437,"source":{"system":"sec-edgar","filing":"0001836067-26-000004","document":"wk-form4_1772056270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000004/wk-form4_1772056270.xml","form_type":"4"}},{"id":882144,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:51:15.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":369,"price":50.86,"value":18767.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":12187,"source":{"system":"sec-edgar","filing":"0001836067-26-000004","document":"wk-form4_1772056270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000004/wk-form4_1772056270.xml","form_type":"4"}},{"id":882143,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:51:15.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12556,"source":{"system":"sec-edgar","filing":"0001836067-26-000004","document":"wk-form4_1772056270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000004/wk-form4_1772056270.xml","form_type":"4"}},{"id":882142,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:51:15.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":603,"price":51.35,"value":30964.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":11806,"source":{"system":"sec-edgar","filing":"0001836067-26-000004","document":"wk-form4_1772056270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000004/wk-form4_1772056270.xml","form_type":"4"}},{"id":882141,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-25T21:51:15.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":1125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12409,"source":{"system":"sec-edgar","filing":"0001836067-26-000004","document":"wk-form4_1772056270.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000004/wk-form4_1772056270.xml","form_type":"4"}},{"id":890836,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-20T21:47:37.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001836067-26-000002","document":"wk-form4_1771624054.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000002/wk-form4_1771624054.xml","form_type":"4"}},{"id":890835,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-02-20T21:47:37.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on February 18, 2027."}],"balance_after":13500,"derivative":{"exercise_price":50.2,"expiration_date":"2036-02-18","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001836067-26-000002","document":"wk-form4_1771624054.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606726000002/wk-form4_1771624054.xml","form_type":"4"}},{"id":1031783,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2025-09-26T20:17:29.000Z","date":"2025-09-25","kind":"exercise","planned":false,"acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001836067-25-000006","document":"wk-form4_1758917846.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606725000006/wk-form4_1758917846.xml","form_type":"4"}},{"id":1031782,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-09-26T20:17:29.000Z","date":"2025-09-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":840,"price":46.21,"value":38816.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":11015,"source":{"system":"sec-edgar","filing":"0001836067-25-000006","document":"wk-form4_1758917846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606725000006/wk-form4_1758917846.xml","form_type":"4"}},{"id":1031781,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-09-26T20:17:29.000Z","date":"2025-09-25","kind":"exercise","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024."}],"balance_after":11855,"source":{"system":"sec-edgar","filing":"0001836067-25-000006","document":"wk-form4_1758917846.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606725000006/wk-form4_1758917846.xml","form_type":"4"}},{"id":1041678,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2025-09-12T20:07:11.000Z","date":"2025-09-10","kind":"grant","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":1875,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001836067-25-000004","document":"wk-form4_1757707628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000183606725000004/wk-form4_1757707628.xml","form_type":"4"}},{"id":1222817,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:14:47.000Z","date":"2025-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":577,"price":33.05,"value":19069.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units."}],"balance_after":9635,"source":{"system":"sec-edgar","filing":"0001628280-25-010437","document":"wk-form4_1741209276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025010437/wk-form4_1741209276.xml","form_type":"4"}},{"id":1222816,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:14:47.000Z","date":"2025-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":577,"price":33.05,"value":19069.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units."}],"balance_after":10212,"source":{"system":"sec-edgar","filing":"0001628280-25-010437","document":"wk-form4_1741209276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025010437/wk-form4_1741209276.xml","form_type":"4"}},{"id":1222815,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:14:47.000Z","date":"2025-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":314,"price":33.05,"value":10377.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Restricted Stock Units."}],"balance_after":10789,"source":{"system":"sec-edgar","filing":"0001628280-25-010437","document":"wk-form4_1741209276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025010437/wk-form4_1741209276.xml","form_type":"4"}},{"id":1249837,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-25T01:20:14.000Z","date":"2025-02-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":2500,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001628280-25-007532","document":"wk-form4_1740446408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025007532/wk-form4_1740446408.xml","form_type":"4"}},{"id":1249836,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-25T01:20:14.000Z","date":"2025-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001628280-25-007532","document":"wk-form4_1740446408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025007532/wk-form4_1740446408.xml","form_type":"4"}},{"id":1249835,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-25T01:20:14.000Z","date":"2025-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."}],"balance_after":750,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001628280-25-007532","document":"wk-form4_1740446408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025007532/wk-form4_1740446408.xml","form_type":"4"}},{"id":1249834,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Units","published_at":"2025-02-25T01:20:14.000Z","date":"2025-02-21","kind":"exercise","planned":false,"acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001628280-25-007532","document":"wk-form4_1740446408.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025007532/wk-form4_1740446408.xml","form_type":"4"}},{"id":1249833,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-25T01:20:14.000Z","date":"2025-02-23","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":11103,"source":{"system":"sec-edgar","filing":"0001628280-25-007532","document":"wk-form4_1740446408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025007532/wk-form4_1740446408.xml","form_type":"4"}},{"id":1249832,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-25T01:20:14.000Z","date":"2025-02-22","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9853,"source":{"system":"sec-edgar","filing":"0001628280-25-007532","document":"wk-form4_1740446408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025007532/wk-form4_1740446408.xml","form_type":"4"}},{"id":1249831,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-25T01:20:14.000Z","date":"2025-02-22","kind":"grant","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8603,"source":{"system":"sec-edgar","filing":"0001628280-25-007532","document":"wk-form4_1740446408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025007532/wk-form4_1740446408.xml","form_type":"4"}},{"id":1249830,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-25T01:20:14.000Z","date":"2025-02-21","kind":"sale","planned":false,"acquired":false,"shares":927,"price":39.15,"value":36292.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":7853,"source":{"system":"sec-edgar","filing":"0001628280-25-007532","document":"wk-form4_1740446408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025007532/wk-form4_1740446408.xml","form_type":"4"}},{"id":1249829,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-02-25T01:20:14.000Z","date":"2025-02-21","kind":"exercise","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024."}],"balance_after":8780,"source":{"system":"sec-edgar","filing":"0001628280-25-007532","document":"wk-form4_1740446408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025007532/wk-form4_1740446408.xml","form_type":"4"}},{"id":1253136,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-02-21T21:44:36.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 19, 2026."}],"balance_after":4500,"derivative":{"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001628280-25-007165","document":"wk-form4_1740174269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025007165/wk-form4_1740174269.xml","form_type":"4"}},{"id":1253135,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-02-21T21:44:36.000Z","date":"2025-02-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in four equal annual installments beginning on February 19, 2026."}],"balance_after":20000,"derivative":{"exercise_price":33.52,"expiration_date":"2035-02-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-25-007165","document":"wk-form4_1740174269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025007165/wk-form4_1740174269.xml","form_type":"4"}},{"id":1291937,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Units","published_at":"2025-01-29T22:01:18.000Z","date":"2025-01-28","kind":"grant","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units, a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":1875,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001628280-25-003016","document":"wk-form4_1738188071.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828025003016/wk-form4_1738188071.xml","form_type":"4"}},{"id":1320460,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2024-12-30T21:13:12.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001628280-24-052575","document":"wk-form4_1735593186.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828024052575/wk-form4_1735593186.xml","form_type":"4"}},{"id":1320459,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2024-12-30T21:13:12.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001628280-24-052575","document":"wk-form4_1735593186.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828024052575/wk-form4_1735593186.xml","form_type":"4"}},{"id":1320458,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-30T21:13:12.000Z","date":"2024-12-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":821,"price":35.59,"value":29219.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":6595,"source":{"system":"sec-edgar","filing":"0001628280-24-052575","document":"wk-form4_1735593186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828024052575/wk-form4_1735593186.xml","form_type":"4"}},{"id":1320457,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-30T21:13:12.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024."}],"balance_after":7416,"source":{"system":"sec-edgar","filing":"0001628280-24-052575","document":"wk-form4_1735593186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828024052575/wk-form4_1735593186.xml","form_type":"4"}},{"id":1320456,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-30T21:13:12.000Z","date":"2024-12-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":281,"price":35.59,"value":10000.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":5541,"source":{"system":"sec-edgar","filing":"0001628280-24-052575","document":"wk-form4_1735593186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828024052575/wk-form4_1735593186.xml","form_type":"4"}},{"id":1320455,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-12-30T21:13:12.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 431 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":5822,"source":{"system":"sec-edgar","filing":"0001628280-24-052575","document":"wk-form4_1735593186.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828024052575/wk-form4_1735593186.xml","form_type":"4"}},{"id":1321766,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2024-12-26T13:31:07.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024."}],"balance_after":1875,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001628280-24-052395","document":"wk-form4_1735219861.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828024052395/wk-form4_1735219861.xml","form_type":"4"}},{"id":1321765,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2024-12-26T13:31:07.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024."}],"balance_after":750,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001628280-24-052395","document":"wk-form4_1735219861.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000162828024052395/wk-form4_1735219861.xml","form_type":"4"}},{"id":1616169,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-27T22:00:51.000Z","date":"2024-02-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 23, 2024."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":1250},"source":{"system":"sec-edgar","filing":"0001104659-24-028272","document":"tm247055-23_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465924028272/tm247055-23_4seq1.xml","form_type":"4"}},{"id":1616168,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-27T22:00:51.000Z","date":"2024-02-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":567,"price":29.06,"value":16477.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":4641,"source":{"system":"sec-edgar","filing":"0001104659-24-028272","document":"tm247055-23_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465924028272/tm247055-23_4seq1.xml","form_type":"4"}},{"id":1616167,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-27T22:00:51.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":1250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5208,"source":{"system":"sec-edgar","filing":"0001104659-24-028272","document":"tm247055-23_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465924028272/tm247055-23_4seq1.xml","form_type":"4"}},{"id":1619754,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2024-02-26T22:02:36.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in four equal annual installments beginning on February 22, 2025."}],"balance_after":25000,"derivative":{"exercise_price":27.94,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-24-027581","document":"tm247055-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465924027581/tm247055-12_4seq1.xml","form_type":"4"}},{"id":1619753,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-26T22:02:36.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2025."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-24-027581","document":"tm247055-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465924027581/tm247055-12_4seq1.xml","form_type":"4"}},{"id":1619752,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-02-26T22:02:36.000Z","date":"2024-02-22","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023."}],"balance_after":1500,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001104659-24-027581","document":"tm247055-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465924027581/tm247055-12_4seq1.xml","form_type":"4"}},{"id":1619751,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-26T22:02:36.000Z","date":"2024-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":303,"price":27.94,"value":8465.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":3958,"source":{"system":"sec-edgar","filing":"0001104659-24-027581","document":"tm247055-12_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465924027581/tm247055-12_4seq1.xml","form_type":"4"}},{"id":1619750,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-02-26T22:02:36.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 268 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":4261,"source":{"system":"sec-edgar","filing":"0001104659-24-027581","document":"tm247055-12_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465924027581/tm247055-12_4seq1.xml","form_type":"4"}},{"id":1700192,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2023-12-26T22:01:22.000Z","date":"2023-12-22","kind":"exercise","planned":false,"acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001104659-23-129243","document":"tm2333640-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465923129243/tm2333640-2_4seq1.xml","form_type":"4"}},{"id":1700191,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-26T22:01:22.000Z","date":"2023-12-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":204,"price":27.66,"value":5642.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units."}],"balance_after":3243,"source":{"system":"sec-edgar","filing":"0001104659-23-129243","document":"tm2333640-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465923129243/tm2333640-2_4seq1.xml","form_type":"4"}},{"id":1700190,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-12-26T22:01:22.000Z","date":"2023-12-22","kind":"exercise","planned":false,"acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2022."}],"balance_after":3447,"source":{"system":"sec-edgar","filing":"0001104659-23-129243","document":"tm2333640-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465923129243/tm2333640-2_4seq1.xml","form_type":"4"}},{"id":1707442,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2023-12-18T22:00:33.000Z","date":"2023-12-14","kind":"grant","planned":false,"acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 22, 2022, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on May 3, 2022."}],"balance_after":600,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001104659-23-126930","document":"tm2333121-1_4seq2.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465923126930/tm2333121-1_4seq2.xml","form_type":"4"}},{"id":1990602,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-27T22:03:50.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 23, 2024."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-23-026088","document":"tm237737-20_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465923026088/tm237737-20_4seq1.xml","form_type":"4"}},{"id":1990601,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-02-27T22:03:50.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 23, 2024."}],"balance_after":20000,"derivative":{"exercise_price":38.6,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-23-026088","document":"tm237737-20_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465923026088/tm237737-20_4seq1.xml","form_type":"4"}},{"id":1993548,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-02-24T22:00:52.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023."}],"balance_after":2250,"derivative":{"underlying":"Common Stock","underlying_shares":750},"source":{"system":"sec-edgar","filing":"0001104659-23-025366","document":"tm237737-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465923025366/tm237737-6_4seq1.xml","form_type":"4"}},{"id":1993547,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-24T22:00:52.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes an aggregate of 247 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan."}],"balance_after":2497,"source":{"system":"sec-edgar","filing":"0001104659-23-025366","document":"tm237737-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465923025366/tm237737-6_4seq1.xml","form_type":"4"}},{"id":2003816,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2023-02-21T22:01:38.000Z","date":"2023-02-16","kind":"exercise","acquired":false,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 30 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-23-023832","document":"tm237193-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465923023832/tm237193-2_4seq1.xml","form_type":"4"}},{"id":2003815,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-02-21T22:01:38.000Z","date":"2023-02-16","kind":"exercise","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on April 30, 2021."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001104659-23-023832","document":"tm237193-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465923023832/tm237193-2_4seq1.xml","form_type":"4"}},{"id":2053821,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP, Chief Medical Officer"}}],"security":"Performance Share Unit","published_at":"2023-01-17T22:00:25.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 30 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period."}],"balance_after":1500,"derivative":{"exercise_price":0,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001104659-23-004285","document":"tm233672-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465923004285/tm233672-1_4seq1.xml","form_type":"4"}},{"id":2372383,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T22:15:04.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-22-027392","document":"tm227764-2_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465922027392/tm227764-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-02-24"}},{"id":2372382,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-25T22:15:04.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 22, 2023."}],"balance_after":25000,"derivative":{"exercise_price":32.2,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-22-027392","document":"tm227764-2_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465922027392/tm227764-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-02-24"}},{"id":2375037,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T02:24:26.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."}],"balance_after":3000,"derivative":{"underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001104659-22-026877","document":"tm227622-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465922026877/tm227622-10_4seq1.xml","form_type":"4"}},{"id":2375036,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-02-25T02:24:26.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 22, 2023."}],"balance_after":25000,"derivative":{"exercise_price":32.2,"expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-22-026877","document":"tm227622-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465922026877/tm227622-10_4seq1.xml","form_type":"4"}},{"id":2839802,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":23374,"kind":"person","name":"Rubin Jonathan","position":1,"cik":"0001836067","reported_name":"Rubin Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-23T23:54:42.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal annual installments beginning on February 19, 2022."}],"balance_after":25000,"derivative":{"exercise_price":29.61,"expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-21-026939","document":"tm217706-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1836067/000110465921026939/tm217706-10_4seq1.xml","form_type":"4"}}]}